Clinical Trial Update: Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia [NA]

View source ↗

Summary

A clinical trial comparing an anti-arrhythmic medication to MRI-guided ablation for ventricular tachycardia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Drugs mentioned

• Anti-arrhythmic medication (not specified)

Snippet

Sponsor: Johns Hopkins University | Conditions: Ventricular Tachycardia | NA | Status: WITHDRAWN